LSE - Delayed Quote GBp

Inspiration Healthcare Group plc (IHC.L)

31.50 0.00 (0.00%)
At close: April 26 at 2:13 PM GMT+1
Key Events
Loading Chart for IHC.L
DELL
  • Previous Close 31.50
  • Open 31.99
  • Bid 31.00 x --
  • Ask --
  • Day's Range 31.02 - 31.99
  • 52 Week Range 28.00 - 57.90
  • Volume 13,008
  • Avg. Volume 95,706
  • Market Cap (intraday) 21.494M
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.01
  • Earnings Date --
  • Forward Dividend & Yield 0.01 (1.95%)
  • Ex-Dividend Date Nov 23, 2023
  • 1y Target Est 160.00

Inspiration Healthcare Group plc, together with its subsidiaries, supplies medical technology for critical care, operating theatre, and home healthcare applications worldwide. The company provides SLE6000, a technology for little lungs; LifeStart, a bedside resuscitation unit; First Breath, a neonatal non-invasive support; Inspire rPAP, a 2-piece non-invasive system for the resuscitation of infants; Genedrive MT-RNR1 system, a care genetic test used to detect mitochondrial gene MT-RNR1 in human buccal cells; Unique+ cerebral function monitoring (CFM) used to help in the diagnosis of brain injury; and push-to-set intermittent, paediatric intermittent, neonatal intermittent, and 2-Mode Continuous regulators, as well as Ohio medical MRI compatible vacuum regulators. It offers inspire nCPAP used for treating infants; anatomical face masks; mini stat CO2, stat CO2, and neostat CO2; ALGOPEDOL; and heel warmers products. In addition, the company birdy, a positioning cushions support for infant; traveller RS restraint system for mobile incubators; IncuCap, an incubator and phototherapy; MaviLED phototherapy, a tool in the treatment of neonatal hyperbilirubinemia; FirstBreathTM dual heated breathing circuit; and FirstBreathTM single heated breathing circuit with water trap. Further, it offers Alphacore5 controller; and Viomedex surgical skin markers. Inspiration Healthcare Group plc was founded in 1998 and is based in Croydon, the United Kingdom.

www.inspiration-healthcare.com

210

Full Time Employees

January 31

Fiscal Year Ends

Recent News: IHC.L

Performance Overview: IHC.L

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IHC.L
21.25%
FTSE 100
5.26%

1-Year Return

IHC.L
38.05%
FTSE 100
3.15%

3-Year Return

IHC.L
73.11%
FTSE 100
17.31%

5-Year Return

IHC.L
53.74%
FTSE 100
9.49%

Compare To: IHC.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IHC.L

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    21.49M

  • Enterprise Value

    30.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.53

  • Price/Book (mrq)

    0.61

  • Enterprise Value/Revenue

    0.73

  • Enterprise Value/EBITDA

    15.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.34%

  • Return on Assets (ttm)

    0.49%

  • Return on Equity (ttm)

    -1.56%

  • Revenue (ttm)

    41.08M

  • Net Income Avi to Common (ttm)

    -550k

  • Diluted EPS (ttm)

    -0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.95M

  • Total Debt/Equity (mrq)

    30.15%

  • Levered Free Cash Flow (ttm)

    -4.04M

Research Analysis: IHC.L

Analyst Price Targets

70.00
160.00 Average
31.50 Current
250.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: IHC.L

People Also Watch